Copyright HMP 2014 For non-commercial use only

Size: px
Start display at page:

Download "Copyright HMP 2014 For non-commercial use only"

Transcription

1 Original Contribution Same-Day Discharge or Stay After Percutaneous Coronary Intervention: Comparison of Net Adverse Cardiovascular Events Francisco O. Nascimento, MD 1, Andres M. Pineda, MD 1, Alexandre Benjo, MD 1, Ildefonso Mas, Jr, MD 1,2, Carlos Podesta, MD 2, Todd B. Heimowitz, DO 1, Ajay Kirtane, MD 3, Nirat Beohar, MD 1 Abstract: Background. Same-day discharge after percutaneous coronary intervention (PCI), if achieved with acceptable safety, could result in greater patient satisfaction and potential cost savings. Comparative analyses reporting the safety outcomes of same-day discharge vs overnight stay after elective PCI are lacking. Methods. Data of same-day discharge and overnight-stay patients undergoing elective PCI in a high-volume center were compared. We specifically evaluated the incidence of net adverse cardiovascular events (NACE; ie, death, myocardial infarction, stroke, target vessel revascularization, vascular complication, and major bleeding) within 48 hours post index procedure among both groups and at 30 days. Results. A total of 188 cases were evaluated, with 93 discharged the same day and 95 after overnight stay following elective PCI. Baseline characteristics were similar, except for older age (73.0 ± 7 years vs 64.0 ± 12 years; P<.001), more prior PCI (49.5% vs 34.7%; P<.001), and prior coronary artery bypass graft surgery (16.1% vs 11.6%; P=.01) in the same-day discharge group. Procedural characteristics were similar in both groups. No significant difference in the NACE rate was found between the groups at 48 hours (0 [0%] vs 2 [2.1%]; P=.25) or at 30 days (3 [3.2%] vs 6 [6.3%]; P=.26). Conclusion. In the population studied, same-day discharge after PCI is safe and feasible. Adequately powered randomized prospective studies are necessary to confirm these results. J INVASIVE CARDIOL 2014;26(5): Key words: same-day discharge, day case, overnight stay, percutaneous coronary intervention Percutaneous coronary interventions (PCIs) are some of the most commonly performed cardiovascular procedures in current medical practice. Given the cost considerations of these procedures as well as improvements in procedural safety, considerable attention is being given to the rapidity of hospital bed turnover, staffing management, and healthcare expenditure related to PCIs. While a majority of diagnostic catheterizations are performed on an outpatient basis, overnight stay (ONS) is still the standard practice for patients who undergo PCI per current guidelines. 1,2 The concern is primarily due to potential abrupt vessel closure, which was From the 1 Mount Sinai Heart Institute, Miami Beach, Florida, 2 Leon Medical Center, Miami, Florida, and 3 Columbia University Medical Center and The Cardiovascular Research Foundation, New York City, New York. Disclosure: The authors have completed and returned the ICMJE Form for Disclosure of Potential Conflicts of Interest. The authors report no conflicts of interest regarding the content herein. Manuscript submitted July 8, 2013 and accepted December 16, Address for correspondence: Francisco O. Nascimento, MD, Columbia University, Division of Cardiology, Mount Sinai Heart Institute, 4300 Alton Road, Miami Beach, FL fonasci@gmail.com ACT: CABG: SD: SDD: NACE: ONS: PCI: activated clotting time coronary artery bypass grafting standard deviation same-day discharge net adverse cardiovascular events overnight stay percutaneous coronary intervention as high as 30% in the plain old balloon angioplasty (POBA) era, and vascular access-site complications after discharge. 3,4 However, the frequent uses of stents, development and miniaturization of interventional cardiology armamentarium, and adjuvant pharmacology have improved the safety and success of PCI procedures. 5 Some studies have suggested that outpatient PCI performed via the transradial approach is feasible in selected patients, whereas others have described evidence of the safety of same-day discharge (SDD) after PCI via transfemoral access. However, these studies have evaluated selected low-risk populations, and frequently lack control groups for comparison of outcomes Cohort studies with all-comer data reporting safety outcomes of SDD after elective PCI are sparse, and case series evaluating combined ad hoc PCI with femoral access are lacking. We aimed to evaluate the net adverse cardiovascular event (NACE) rate within 48 hours and at 30 days on all-comer patients who underwent PCI and were managed with a SDD strategy in comparison to an ONS control group. Methods Study cohort. After the study protocol was approved by the local institutional review board, retrospective data were collected on 93 consecutive patients discharged on the same day after an uncomplicated elective PCI performed at the Mount Sinai Medical Center in Miami Beach, Florida, from January 2011 through January In order to obtain matched cases in terms of procedural characteristics, retrospective data of 95 consecutive patients who underwent uncomplicated elective PCI and stayed overnight in the hospital for routine observation were collected to serve as the control group. In both groups, the inclusion criteria included: (1) elective PCI for stable angina, stable angina with a positive stress test or crescendo angina, or asymptomatic but positive stress test or perfusion imaging or stenosis on coronary 204 The Journal of Invasive Cardiology

2 Table 1. Baseline characteristics. computerized tomography; (2) successful PCI; (3) no angiographic evidence of untreated intimal dissection; (4) absence of unresolved/unexplained postprocedural chest pain; (5) absence of vascular complications at completion of PCI; and (7) PCI performed before 3 pm to allow 6 hours of observation before discharge on the same day. The cases were excluded if any of the following criteria was met: (1) non-st elevation myocardial infarction or ST-elevation myocardial infarction as indication for PCI; (2) complex PCI (unprotected left main intervention, atherectomy, chronic total occlusions, or interventions on a last remaining vessel); (3) significant procedural complications (prolonged chest pain, transient closure, no-flow or slow-flow phenomenon, hemodynamic instability, persistent electrocardiographic changes, major side-branch occlusion, or an angiographically suboptimal result); (4) unresolved periprocedural hemodynamic or Age (years) 73.0 ± ± 12 <.001 Males 74 (79.6%) 70 (73.3%).22 Diabetes mellitus 30 (32.3%) 38 (40.0%).17 Hypertension 81 (87.1%) 76 (80.0%).13 Chronic kidney disease 9 (9.7%) 15 (15.8%).22 Dyslipidemia 60 (64.5%) 67 (70.5%).24 Peripheral artery disease 7 (7.5%) 8 (8.4%).52 Smoker 26 (28.0%) 28 (29.5%).47 Valvular heart disease 29 (31.2%) 19 (20.0%).06 Prior myocardial infarction 32 (34.4%) 16 (16.8%).50 Prior PCI 46 (49.5%) 33 (34.7%) <.001 Prior CABG 15 (16.1%) 11 (11.6%).01 PCI = percutaneous coronary intervention; CABG = coronary artery bypass graft surgery. Table 2. Procedural characteristics. Femoral access 93 (100%) 95 (100%) >.99 Drug-eluting stent 83 (89.2%) 78 (82.1%).83 Closure device 69 (74.2%) 66 (69.5%).29 Multivessel PCI 14 (15.1%) 24 (25.3%).07 Bifurcation 19 (20.4%) 13 (13.7%).15 Proximal LAD 18 (19.4%) 24 (25.3%).21 Protected left main 4 (4.3%) 2 (2.1%).33 Bivalirudin 73 (78.8%) 77 (81.1%).40 Heparin 19 (20.4%) 23 (24.2%).33 GP IIb/IIIa inhibitors 3 (3.2%) 10 (10.5%).08 Prior PCI 46 (49.5%) 33 (34.7%) <.001 PCI = percutaneous coronary intervention; LAD = left anterior descending coronary artery; GP = glycoprotein. Same-Day Discharge After PCI electrical instability; or (5) serum creatinine greater than 2.0 mg/dl. Of note, multivessel PCI was not an exclusion criterion. Ten patients in the SDD group and 8 patients in the ONS group were excluded due to missed follow-up. Procedural details. Percutaneous coronary intervention was performed via the femoral approach using 6-7 Fr guiding catheters. All patients were pretreated with aspirin 325 mg and clopidogrel 300 to 600 mg orally before the procedure. The anticoagulation protocol included either intravenous bivalirudin or intravenous heparin with or without glycoprotein IIb/IIIa inhibitors. Procedural success was defined as the establishment of postprocedural TIMI-3 flow, no residual hemodynamically significant dissection or major sidebranch loss, and less than 10% residual stenosis after stent deployment. Vascular access management. Hemostasis following transfemoral accesses was achieved with closure devices, which included Perclose (Abbott Laboratories) and Angio-Seal (St Jude Medical), or by manual compression 2-3 hours after PCI (once activated clotting time was <170 s). Postintervention care. After PCI, patients were observed in the postprocedure telemetry care unit by skilled staff trained to manage post-pci complications. All patients were ambulated after 4 hours of bed rest if a closure device was used or after 6 hours if the sheath was removed manually. Written instructions and oral explanation regarding activities, medication compliance, and follow-up were given to all patients. Follow-up. All patients were scheduled for an office visit with the referring cardiologist or the interventional cardiologist in 2-4 days and then at 4-6 weeks after the index procedure. Study outcomes. The 48-hour and 30-day NACE rates included the rates of all-cause death, myocardial infarction, repeat target vessel revascularization, major access-site vascular complications, major bleeding, and any stroke within 30 days of index PCI. All events were adjudicated by 2 investigators (AMP and AB) who were not involved in performing the procedures. The death rate was calculated by evaluating hospital medical records and social security number survey. Myocardial infarction was defined in accordance with the universal definition proposed in Stroke was defined as focal loss of neurologic function caused by an ischemic or hemorrhagic event, with residual symptoms lasting at least 24 hours or leading to death. 21 Major bleeding was defined as fatal bleeding, intracranial bleeding, intrapericardial bleeding with cardiac tamponade, hypovolemic shock or severe hypotension due to bleeding and requiring pressors or surgery, and bleeding either associated with a drop in the hemoglobin level of at least 3 g/dl or requiring transfusion of 1 or more units of red cells. Minor bleeding was defined as any bleeding requiring medical intervention but not meeting the criteria for major bleeding. Major vascular complications included the occurrence of one or several of the following: retroperitoneal bleeding, pseudoaneurysm or arteriovenous fistula formation, thrombosis or dissection, or need for vascular surgery. Minor Vol. 26, No. 5, May

3 NASCIMENTO, et al. Table hour outcomes. vascular complications were defined as any hematoma up to 10 cm in diameter, and which did not meet criteria for major vascular complication. Statistical analysis. Statistical analysis was performed using SPSS version 17 (SPSS Institute). Continuous variables are presented as mean ± 1 standard deviation and compared using the unpaired student s T-test. Categorical data are presented as frequencies and compared using Fisher s exact test (Chi-square). Significance was assumed when P<.05. Results Data of 188 patients who underwent uncomplicated elective PCI from January 2011 through January 2012 were reviewed and analyzed. This corresponds to 15.3% of all PCIs performed at our institution over this period. Of those, 93 were consecutive patients discharged on the same day and 95 were consecutive patients who stayed overnight for observation after elective PCI. The baseline characteristics are demonstrated in Table 1. The patients in the SDD group were older than in the ONS group (73.0 ± 7 years vs 64.0 ± 12 years; P<.001) and had a more frequent history of prior PCI (46 [49.5%] vs 33 [34.7%]; P<.001) and prior CABG (15 [16.1%] vs 11 [11.6%]; P=.01). There was no statistically significant difference in the distribution of male sex, diabetes mellitus, hypertension, chronic kidney disease, dyslipidemia, peripheral 48-hour composite NACE 0 (0%) 2 (2.1%).25 All-cause mortality 0 (0%) 0 (0%) >.99 Major bleeding 0 (0%) 0 (0%) >.99 Vascular (major) 0 (0%) 0 (0%) >.99 Target vessel revascularization 0 (0%) 0 (0%) >.99 Myocardial infarction 0 (0%) 2 (2.1%).25 Any stroke 0 (0%) 0 (0%) >.99 NACE = composite of all-cause mortality, major bleeding, major vascular complication, target vessel revascularization, myocardial infarction, and any stroke. Table day outcomes. 30-day composite NACE 3 (3.2%) 6 (6.3%).26 All-cause mortality 0 (0%) 1 (1.1%).50 Major bleeding 0 (0%) 0 (0%) >.99 Vascular (major) 0 (0%) 0 (0%) >.99 Target vessel revascularization 2 (2.2%) 1 (1.1%).18 Myocardial infarction 1 (1.1%) 4 (4.2%).19 Any stroke 0 (0%) 0 (0%) >.99 NACE = composite of all-cause mortality, major bleeding, major vascular complication, target vessel revascularization, myocardial infarction, and any stroke. artery disease, smoking, history of prior myocardial infarction, and concomitant valvular heart disease. Procedural characteristics are shown in Table 2. There was no statistically significant difference in the use of drug-eluting stent (DES) implantation, closure devices, multivessel PCI, bifurcation lesion PCI, or proximal left anterior descending PCI. There was no significant difference in the use of bivalirudin or heparin between groups. The 48-hour outcomes are illustrated in Table 3. No statistical difference was found between both groups in the rate of composite NACE or in the individual complication rates. There was no death within 48 hours in either group. Overall NACE events occurred in no SDD patients and in 2 ONS patients (2.1%), with no statistically significant difference between groups (P=.25). Both cases counted for NACE were of myocardial infarction (0 patients in the SDD group and 2 patients (2.1%) in the ONS group; P=.25). No major bleeding occurred in either group. There was no minor bleeding in the SDD group and 2 patients (2.1%) in the ONS group (P=.25). There were no major vascular complications (retroperitoneal bleeding, pseudoaneurysm or arteriovenous fistula formation, thrombosis, or dissection) in either group. Minor vascular complications occurred in 2 patients (2.2%) in the SDD group and 5 patients (5.3%) in the ONS group (P=.23). There was no target vessel revascularization or stroke in any patient of either group within the initial 48 hours. The 30-day outcomes are illustrated in Table 4. No statistical difference was found between both groups in the rate of composite NACE or in the individual complication rates. There was no death at 30 days in the SDD group, whereas 1 patient from the ONS group has died from noncardiovascular causes (P=.51). Overall NACE events occurred in 3 SDD patients (3.2%) and 6 ONS patients (6.3%), with no statistically significant difference between groups (P=.26). No major bleeding occurred in either group. There were no major vascular complications (retroperitoneal bleeding, pseudoaneurysm or arteriovenous fistula formation, thrombosis,or dissection) in either group. Two patients (2.2%) from SDD group and 1 patient (1.1%) from the ONS group underwent target vessel revascularization (P=.18). One patient (1.1%) from the SDD group and 4 patients (4.2%) from the ONS group had myocardial infarction (P=.19). There was no stroke in any patient of either group. Discussion Same-day discharge after PCI, if achieved with acceptable safety, could result in greater patient satisfaction and potential cost savings. Since the late 1990s, outpatient intervention has attracted interest from medical providers and institutions, given the exponential increase in the number of procedures performed, and the consequent need for increased staffing, increased case load on existing staff, hospital bed turnover, and healthcare expenditure that ONS after PCI provokes The Journal of Invasive Cardiology

4 Same-Day Discharge After PCI Table 5. Suggested inclusion and exclusion criteria for same-day discharge post PCI. Inclusion Criteria Exclusion Criteria 1. Elective PCI for stable or crescendo angina, or asymptomatic but positive stress test or stenosis on coronary computerized tomography Despite the logistic and economic burden it causes, traditional protocols for ONS following PCI have not been changed due to patient safety reasons, and current guidelines regarding length of stay (LOS) after PCI still recommend ONS, except in selected low-risk patients. 1 Despite significant improvement in interventional technology in recent years, there has been only marginal reduction in the post-pci LOS; the LOS following PCI is one of the major determinants of hospital cost and quality of care assessment. 5 Our investigation at a large-volume, multioperator institution analyzing a population of elective PCIs, evaluated whether major outcomes within 48 hours and at 30 days post PCI would be different between SDD and ONS patients data that are lacking in current literature. The analysis of individual adverse events or composite major adverse cardiac and cardiovascular events showed no difference in a fairly homogeneous sample of patients for both analyzed periods. The baseline characteristics of the population would suggest that the patients in the SDD group were potentially even more prone to have a worse outcome than ONS group, given that they were older, and had more prior PCIs and prior history of CABG. Instead, there was no difference in the event rate. Another feature of the population studied is that higher-risk cases were included. We had a considerable amount of multivessel interventions (15.1%), bifurcation lesions (20.4%), and proximal left anterior descending PCIs (19.4%) in the SDD group, which potentially increases the risk for complications. Several observational studies without control groups have reported single-center experiences with SDD in the United States, Canada, and Oceania, many of them utilizing transradial access only. 6,7,11,15-17 Despite the advent of radial interventions, the femoral approach is still the favored technique worldwide. 5 These prior studies showed fairly low events, and concluded overall that SDD is a feasible strategy in select 1. Non-ST elevation myocardial infarction or ST-elevation myocardial infarction as indication for PCI 2. Successful PCI 2. Complex PCI (unprotected left main intervention, atherectomy, chronic total occlusions, or interventions on a last remaining vessel) 3. No angiographic evidence of untreated intimal coronary dissection 3. Significant procedural complications (prolonged chest pain, transient closure, no-flow or slow-flow phenomenon, hemodynamic instability, persistent electrocardiographic changes, major side-branch occlusion, or an angiographically suboptimal result) 4. Absence of unresolved postprocedural chest pain 4. Unresolved periprocedural hemodynamic or electrical instability 5. Systolic blood pressure lower than 160 mm Hg at 5. Serum creatinine greater than 2.0 mg/dl the time of discharge 6. Absence of vascular complications at completion of PCI 7. PCI performed before 3 pm to allow 6 hours of observation before discharge on the same day Note: all inclusion and exclusion criteria should be met. PCI = percutaneous coronary intervention. low-risk populations. A larger analysis with unpaired data of over 100,000 patients from the National Cardiovascular Data Registry reported the outcomes of SDD in Medicare patients. 2 In this cross-sectional analysis with large (although unmatched) data, the authors concluded that SDD could be considered in elderly low-risk patients. Heyde et al 8 conducted a large prospective randomized trial in the Netherlands. This study also showed similar outcomes in both groups of SDD and ONS and stated SDD post PCI to be safe and feasible. However, the main exclusion criteria eliminated all ad hoc PCIs, which unlike in Europe, is the most used practice in the United States. More recently, a meta-analysis attempted to combine existing data on post-pci SDD. 25 Despite considerable heterogeneity across published studies comparing SDD after PCI with ONS, with significant variation in the populations studied and the definition of outcomes, the authors concluded that SDD after uncomplicated PCI was a reasonable approach in selected patients. The confirmatory results we obtained in this study, along with prior observational randomized trials and meta-analyses may help to change the paradigm that hospitalization and admission (ie, ONS) is safer and better than SDD post PCI. A recent systematic database review in a broad spectrum of medical patients has suggested that the risk from a simple ONS in the hospital includes skin ulcer formation (0.4%), adverse drug reactions (3.4%), and infection (11.1%), in a clear indication that simply staying longer in the hospital is not necessarily benign. 26 Moreover, the majority of patients seem to prefer the SDD approach when meeting appropriate criteria. 27 Although it is likely that individual centers have created their local protocols for SDD after PCI, there is a lack of standardized selection criteria for this strategy and the existing recommendations in the Society for Cardiovascular Angiography and Interventions (SCAI) statement (endorsed by the American College of Cardiology) on SDD 1 are likely far more Vol. 26, No. 5, May

5 NASCIMENTO, et al. conservative than what the current practice may be. 6,24 Besides the outcomes we reported regarding SDD in low to moderate risk patients after ad hoc PCI, we also suggest selection criteria that are followed at our institution for patients who could potentially be considered for outpatient PCI (Table 5). Study limitations. As a retrospective single-center study, undetectable differences in baseline characteristics may have influenced outcomes. Selection bias given the involvement of multiple operators cannot be ruled out as well as operator bias. Our study was not primarily designed to identify predictors of PCI-related complications for SDD. Conclusion In a low to moderate risk patient population, SDD after ad hoc PCI is safe and feasible; however, careful and appropriate criteria should be standardized and followed. Randomized prospective studies are still needed to confirm or refute the results. References 1. Chambers CE, Dehmer GJ, Cox DA, et al. Defining the length of stay following percutaneous coronary intervention: an expert consensus document from the Society for Cardiovascular Angiography and Interventions. Endorsed by the American College of Cardiology Foundation. Catheter Cardiovasc Interv. 2009;73(7): Rao SV, Kaltenbach LA, Weintraub WS, et al. Prevalence and outcomes of same-day discharge after elective percutaneous coronary intervention among older patients. JAMA. 2011;306(13): Singh M, Rihal CS, Gersh BJ, et al. Twenty-five-year trends in in-hospital and longterm outcome after percutaneous coronary intervention: a single-institution experience. Circulation. 2007;115(22): Sharma SK, Israel DH, Kamean JL, et al. Clinical, angiographic, and procedural determinants of major and minor coronary dissection during angioplasty. Am Heart J. 1993;126(1): Patel M, Kim M, Karajgikar R, et al. Outcomes of patients discharged the same day following percutaneous coronary intervention. JACC Cardiovasc Interv. 2010;3(8): Gilchrist IC, Rhodes DA, Zimmerman HE. A single center experience with sameday transradial-pci patients: a contrast with published guidelines. Catheter Cardiovasc Interv. 2012;79(4): Bertrand OF, De Larochellière R, Rodés-Cabau J, et al. A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation. Circulation. 2006;114(24): Heyde GS, Koch KT, de Winter RJ, et al. Randomized trial comparing sameday discharge with overnight hospital stay after percutaneous coronary intervention: results of the Elective PCI in Outpatient Study (EPOS). Circulation. 2007;115(17): Yee KM, Lazzam C, Richards J, Ross J, Seidelin PH. Same-day discharge after coronary stenting: a feasibility study using a hemostatic femoral puncture closure device. J Interv Cardiol. 2004;17(5): Khater M, Zureikat H, Alqasem A, Alnaber N, Alhaddad IA. Contemporary outpatient percutaneous coronary intervention: feasible and safe. Coron Artery Dis. 2007;18(7): Ziakas AA, Klinke BP, Mildenberger CR, et al. Safety of same-day discharge radial percutaneous coronary intervention: a retrospective study. Am Heart J. 2003;146(4): Van Gaal WJ, Arnold JR, Porto I, et al. Long term outcome of elective day case percutaneous coronary intervention in patients with stable angina. Int J Cardiol. 2008;128(2): Ranchord AM, Prasad S, Seneviratne SK, et al. Same-day discharge is feasible and safe in the majority of elderly patients undergoing elective percutaneous coronary intervention. J Invasive Cardiol. 2010;22(7): Dalby M, Davies J, Rakhit R, Mayet J, Foale R, Davies DW. Feasibility and safety of day-case transfemoral coronary stenting. Catheter Cardiovasc Interv. 2003;60(1): Jabara R, Gadesam R, Pendyala L, et al. Ambulatory discharge after transradial coronary intervention: preliminary US single-center experience (Same-day TransRadial Intervention and Discharge Evaluation, the STRIDE Study). Am Heart J. 2008;156(6): Small A, Klinke P, Della Siega A, et al. Day procedure intervention is safe and complication free in higher risk patients undergoing transradial angioplasty and stenting: the discharge study. Catheter Cardiovasc Interv. 2007;70(7): Chung WJ, Fang HY, Tsai TH, et al. Transradial approach percutaneous coronary interventions in an outpatient clinic. Int Heart J. 2010;51(6): Muthusamy P, Busman DK, Davis AT, Wohns H. Assessment of clinical outcomes related to early discharge after elective percutaneous coronary intervention: COED PCI. Catheter Cardiovasc Interv. 2013;81(1): Ormiston JA, Shaw BL, Panther MJ, et al. Percutaneous coronary intervention with bivalirudin anticoagulation, immediate sheath removal, and early ambulation: a feasibility study with implications for day-stay procedures. Catheter Cardiovasc Interv. 2002;55(3): Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation. 2007;116(22): Levine GN, Bates ER, Blankenship JC, et al ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011;58(24):e44-e Koch KT, Piek JJ, Prins MH, et al. Triage of patients for short-term observation after elective coronary angioplasty. Heart. 2000;83(5): Carere RG, Webb JG, Buller CE, et al. Suture closure of femoral arterial puncture sites after coronary angioplasty followed by same-day discharge. Am Heart J. 2000;139(1 Pt 1): Knopf WD, Cohen-Bernstein C, Ryan J, Heselov K, Yarbrough N, Steahr G. Outpatient PTCA with same day discharge is safe and produces high patient satisfaction level. J Invasive Cardiol. 1999;11(5): Abdelaal E, Rao SV, Gilchrist IC, et al. Same-day discharge compared with overnight hospitalization after uncomplicated percutaneous coronary intervention: a systematic review and meta-analysis. JACC Cardiovasc Interv. 2013;6(2): Hauck K, Zhao X. How dangerous is a day in hospital? A model of adverse events and length of stay for medical inpatients. Med Care. 2011;49(12): Ziakas A, Klinke P, Fretz E, et al. Same-day discharge is preferred by the majority of the patients undergoing radial PCI. J Invasive Cardiol. 2004;16(10): The Journal of Invasive Cardiology

International Journal of Collaborative Research on Internal Medicine & Public Health (IJCRIMPH)

International Journal of Collaborative Research on Internal Medicine & Public Health (IJCRIMPH) Same-day discharge after percutaneous coronary intervention in light of the society for cardiovascular angiography and intervention's proposed guidelines: A single-center experience Yazan Khouri, Sachin

More information

University of Witten/Herdecke, Department of Cardiology 2. University of Bochum, Department of Cardiology 3

University of Witten/Herdecke, Department of Cardiology 2. University of Bochum, Department of Cardiology 3 Safety and efficacy of clip-based vs. suture mediated vascular closure for femoral access hemostasis: A prospective randomized single center study comparing the StarClose and the ProGlide device Oliver

More information

Post-Procedure Care and Same-Day PCI. Arnold Seto, MD, MPA

Post-Procedure Care and Same-Day PCI. Arnold Seto, MD, MPA Post-Procedure Care and Same-Day PCI Arnold Seto, MD, MPA Post-Procedure Care Success of radial program depends upon effective access site management Training of staff critical to increase comfort with

More information

Decrease cost of inpatient stay Decrease bed diversions Improve bed utilization (Interqual Criteria) Patient Satisfaction Reduce patient costs

Decrease cost of inpatient stay Decrease bed diversions Improve bed utilization (Interqual Criteria) Patient Satisfaction Reduce patient costs Decrease cost of inpatient stay Decrease bed diversions Improve bed utilization (Interqual Criteria) Patient Satisfaction Reduce patient costs (family hotel, drive back to the VA for next day pick up)

More information

Endorsed by the American College of Cardiology Foundation

Endorsed by the American College of Cardiology Foundation CORONARY ARTERY DISEASE Catheterization and Cardiovascular Interventions 73:847 858 (2009) Clinical Decision Making Defining the Length of Stay Following Percutaneous Coronary Intervention: An Expert Consensus

More information

Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI

Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI Gamal Abdelhady, Emad Mahmoud Department of interventional

More information

Version 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM

Version 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM Version 4.4 Institutional Outcomes Report 2014Q3 National Outcomes Report 999997 Aggregation Date: Jan 12, 2015 11:59:59 PM Publish Date: Jan 29, 2015 If User desires to publish or otherwise distribute

More information

Overview of Trasradial Approach for Coronary Angiography and Intervention. A/Prof. Phạm Mạnh Hùng, MD.FACC., FESC

Overview of Trasradial Approach for Coronary Angiography and Intervention. A/Prof. Phạm Mạnh Hùng, MD.FACC., FESC Overview of Trasradial Approach for Coronary Angiography and Intervention A/Prof. Phạm Mạnh Hùng, MD.FACC., FESC Outline Historical perspective and current trends Rationale for the radial approach Bleeding

More information

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell

More information

High-Dose Tirofiban Administered as Bolus-Only during Percutaneous Coronary Intervention

High-Dose Tirofiban Administered as Bolus-Only during Percutaneous Coronary Intervention Original Contribution High-Dose Tirofiban Administered as Bolus-Only during Percutaneous Coronary Intervention Jonathan D. Marmur, MD, Shyam Poludasu, MD, Ajay Agarwal, MD, Nagarathna Manjappa MD, Erdal

More information

Abstract Background: Methods: Results: Conclusions:

Abstract Background: Methods: Results: Conclusions: Two-Year Clinical and Angiographic Outcomes of Overlapping Sirolimusversus Paclitaxel- Eluting Stents in the Treatment of Diffuse Long Coronary Lesions Kang-Yin Chen 1,2, Seung-Woon Rha 1, Yong-Jian Li

More information

Transradial vs. Transfemoral Access in STEMI: Should We Randomize?

Transradial vs. Transfemoral Access in STEMI: Should We Randomize? Transradial vs. Transfemoral Access in STEMI: Should We Randomize? Ajay J. Kirtane, MD, SM Center for Interventional Vascular Therapy Columbia University Medical Center / New York Presbyterian Hospital

More information

Cover Page. The handle holds various files of this Leiden University dissertation

Cover Page. The handle  holds various files of this Leiden University dissertation Cover Page The handle http://hdl.handle.net/1887/21543 holds various files of this Leiden University dissertation Author: Dharma, Surya Title: Perspectives in the treatment of cardiovascular disease :

More information

Vascular Closure Techniques

Vascular Closure Techniques Vascular Closure Techniques Femoral Approach Clifford J Kavinsky, MD, PHD Professor of Medicine and pediatrics Associate Director, Center for Congenital and Structural Heart Disease Rush University Medical

More information

LM stenting - Cypher

LM stenting - Cypher LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with

More information

ANGIOPLASTY SUMMIT 2004 Seoul, South Korea APRIL 29-MAY 2, 2004

ANGIOPLASTY SUMMIT 2004 Seoul, South Korea APRIL 29-MAY 2, 2004 ANGIOPLASTY SUMMIT 2004 Seoul, South Korea APRIL 29-MAY 2, 2004 RESULTS OF STUDIES COMPARING TRANSRADIAL AND FEMORAL ANGIOGRAPHY HOWARD A. COHEN, M.D. UNIVERSITY OF PITTSBURGH MEDICAL CENTER PRESBYTERIAN

More information

TRANSRADIAL CARDIAC CATHETERIZATION. Amanda Ryan, DO, Interventional Cardiologist Heart Care Centers of Florida April 13, 2013

TRANSRADIAL CARDIAC CATHETERIZATION. Amanda Ryan, DO, Interventional Cardiologist Heart Care Centers of Florida April 13, 2013 TRANSRADIAL CARDIAC CATHETERIZATION Amanda Ryan, DO, Interventional Cardiologist Heart Care Centers of Florida April 13, 2013 TOPICS Historical perspective and current trends Rationale Bleeding for the

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Valle JA, Tamez H, Abbott JD, et al. Contemporary use and trends in unprotected left main coronary artery percutaneous coronary intervention in the United States: an analysis

More information

Link between effectiveness and cost data Costing was conducted prospectively on the same patient sample as that used in the effectiveness analysis.

Link between effectiveness and cost data Costing was conducted prospectively on the same patient sample as that used in the effectiveness analysis. Heparin after percutaneous intervention (HAPI): a prospective multicenter randomized trial of three heparin regimens after successful coronary intervention Rabah M, Mason D, Muller D W, Hundley R, Kugelmass

More information

The MAIN-COMPARE Study

The MAIN-COMPARE Study Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:

More information

Percutaneous Coronary Interventions Without On-site Cardiac Surgery

Percutaneous Coronary Interventions Without On-site Cardiac Surgery Percutaneous Coronary Interventions Without On-site Cardiac Surgery Hassan Al Zammar, MD,FESC Consultant & Interventional Cardiologist Head of Cardiology Department European Gaza Hospital Palestine European

More information

Current Non-Surgical Cardiac Interventions. By Pam Bayles, RN, BSN

Current Non-Surgical Cardiac Interventions. By Pam Bayles, RN, BSN Current Non-Surgical Cardiac Interventions By Pam Bayles, RN, BSN Balloon Angioplasty & DES A balloon-tipped catheter was first used in 1964 to treat a cause of atherosclerotic disease in a patient s leg

More information

Access Site Complications. Nick Cheshire MD FRCS, Professor of Vascular Surgery Imperial College Healthcare St Mary s Hospital Campus

Access Site Complications. Nick Cheshire MD FRCS, Professor of Vascular Surgery Imperial College Healthcare St Mary s Hospital Campus Access Site Complications Nick Cheshire MD FRCS, Professor of Vascular Surgery Imperial College Healthcare St Mary s Hospital Campus Surgeons & Cardiologists Interventional Cardiology 2008 Eye of a Hawk,

More information

Radial Artery Access Improving Outcomes and Decreasing Costs

Radial Artery Access Improving Outcomes and Decreasing Costs Howard A. Cohen, MD, FACC, FSCAI Director, Division of Cardiac Intervention Co-Director, Cardiac Catheterization Laboratories Lenox Hill Heart & Vascular Institute Institute DISCLOSURE Nothing to disclose

More information

Lessons learned From The National PCI Registry

Lessons learned From The National PCI Registry Lessons learned From The National PCI Registry w a v e On Behalf of The Publication Committee of the National PCI Registry Objectives & Anticipated Achievements To determine the epidemiology of patients

More information

Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?

Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)? Cronicon OPEN ACCESS CARDIOLOGY Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)? Valentin Hristov* Department of Cardiology, Specialized

More information

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol

More information

DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea.

DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea. DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea. In-stent restenosis (ISR) Remains important issue even in the

More information

Supplementary Table S1: Proportion of missing values presents in the original dataset

Supplementary Table S1: Proportion of missing values presents in the original dataset Supplementary Table S1: Proportion of missing values presents in the original dataset Variable Included (%) Missing (%) Age 89067 (100.0) 0 (0.0) Gender 89067 (100.0) 0 (0.0) Smoking status 80706 (90.6)

More information

What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation?

What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation? What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation? Keun-Ho Park, Myung Ho Jeong, Min Goo Lee, Jum Suk Ko,

More information

Bifurcation stenting with BVS

Bifurcation stenting with BVS Bifurcation stenting with BVS Breaking the limits or just breaking the struts? Maciej Lesiak Department of Cardiology University Hospital in Poznan, Poland Disclosure Speaker s name: Maciej Lesiak I have

More information

Vascular closure devices (VCDs) status post

Vascular closure devices (VCDs) status post Vascular Closure Devices: Point-Counterpoint Argument for Use of Vascular Closure Devices Oliver G. Abela, MD 1, Jimmy Diep, MD 2, Chowdhury H. Ahsan, MD 3 From 1 University of Cincinnati College of Medicine,

More information

Jun-Won Lee, Sang Wook Park, Jung-Woo Son, Young Jin Youn, Min-Soo Ahn, Sung Gyun Ahn, Jang-Young Kim, Byung-Soo Yoo, Junghan Yoon, Seung-Hwan Lee

Jun-Won Lee, Sang Wook Park, Jung-Woo Son, Young Jin Youn, Min-Soo Ahn, Sung Gyun Ahn, Jang-Young Kim, Byung-Soo Yoo, Junghan Yoon, Seung-Hwan Lee The procedural success and complication rate of the left distal radial approach for coronary angiography and percutaneous coronary intervention. Prospective observational study (LeDRA) Jun-Won Lee, Sang

More information

Switching from femoral to radial access for coronary angiography in ACS

Switching from femoral to radial access for coronary angiography in ACS ORIGINAL ARTICLE 169 Feasability, bleeding events and impact on door-to-balloon times Switching from femoral to radial access for coronary angiography in ACS Ivano Reho, Martin Sprenger, David Tueller,

More information

An Expedient and Versatile Catheter for Primary STEMI Transradial Catheterization/Intervention

An Expedient and Versatile Catheter for Primary STEMI Transradial Catheterization/Intervention An Expedient and Versatile Catheter for Primary STEMI Transradial Catheterization/Intervention Jack P. Chen, MD, FACC, FSCAI, FCCP Medical Director, Northside Heart Institute, Atlanta, GA and Tak Kwan,

More information

Prevention of Coronary Stent Thrombosis and Restenosis

Prevention of Coronary Stent Thrombosis and Restenosis Prevention of Coronary Stent Thrombosis and Restenosis Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea 9/12/03 Coronary

More information

Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter

Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter Nirat Beohar, MD Associate Professor of Medicine Director Cardiac Catheterization Laboratory, Medical Director Structural

More information

Transradial Artery Approach for Coronary Intervention: Maharat Nakhonratchasima Hospital Experience of The First 20 Cases

Transradial Artery Approach for Coronary Intervention: Maharat Nakhonratchasima Hospital Experience of The First 20 Cases Transradial Artery Approach for Coronary Intervention: Maharat Nakhonratchasima Hospital Experience of The First 20 Cases Pinij Kaewsuwanna M.D. Tongprakob Siriwanij M.D. Cardiovascular Disease Center,

More information

Continuing Medical Education Post-Test

Continuing Medical Education Post-Test Continuing Medical Education Post-Test Based on the information presented in this monograph, please choose one correct response for each of the following questions or statements. Record your answers on

More information

Learning Objectives. Epidemiology of Acute Coronary Syndrome

Learning Objectives. Epidemiology of Acute Coronary Syndrome Cardiovascular Update: Antiplatelet therapy in acute coronary syndromes PHILLIP WEEKS, PHARM.D., BCPS-AQ CARDIOLOGY Learning Objectives Interpret guidelines as they relate to constructing an antiplatelet

More information

Acute Coronary Syndromes

Acute Coronary Syndromes Overview Acute Coronary Syndromes Rabeea Aboufakher, MD, FACC, FSCAI Section Chief of Cardiology Altru Health System Grand Forks, ND Epidemiology Pathophysiology Clinical features and diagnosis STEMI management

More information

Vascular Closure Techniques

Vascular Closure Techniques Vascular Closure Techniques CLIFFORD J. KAVINSKY MD, PHD PROFESSOR OF MEDICINE AND PEDIATRICS DIRECTOR, CARDIOVASCULAR FELLOWSHIP TRAINING PROGRAM DIRECTOR, RUSH CENTER FOR ADULT STRUCTURAL HEART DISEASE

More information

Korea University Guro Hospital, Seoul, Korea * Chonnam National University Hospital, Gwangju, Korea

Korea University Guro Hospital, Seoul, Korea * Chonnam National University Hospital, Gwangju, Korea Left Main Disease versus Non Left Main Disease in Acute Myocardial Infarction Patients in Real world Clinical Practice : Lessons from Korea Acute Myocardial Infarction Registry (KAMIR) Seung-Woon Rha*,

More information

New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.)

New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.) A. ADMINISTRATIVE New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.) 1. Facility Code: 2. Facility Name: 3. Procedure Type (Choose only

More information

How to manage TAVI related vascular complications. Paul TL Chiam MBBS, FRCP, FESC, FACC, FSCAI

How to manage TAVI related vascular complications. Paul TL Chiam MBBS, FRCP, FESC, FACC, FSCAI How to manage TAVI related vascular complications Paul TL Chiam MBBS, FRCP, FESC, FACC, FSCAI Definition VARC-2 consensus statement Complications caused by: Wire Catheter Anything related to vascular access

More information

Unstable angina and NSTEMI

Unstable angina and NSTEMI Issue date: March 2010 Unstable angina and NSTEMI The early management of unstable angina and non-st-segment-elevation myocardial infarction This guideline updates and replaces recommendations for the

More information

Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center

Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center Aging Research Volume 2013, Article ID 471026, 4 pages http://dx.doi.org/10.1155/2013/471026 Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at

More information

Bivalirudin Clinical Trials Update Evidence and Future Perspectives

Bivalirudin Clinical Trials Update Evidence and Future Perspectives Bivalirudin Clinical Trials Update Evidence and Future Perspectives Andreas Baumbach Consultant Cardiologist/ hon. Reader in Cardiology Bristol Heart Institute University Hospitals Bristol MY CONFLICTS

More information

Scottish Medicines Consortium

Scottish Medicines Consortium Scottish Medicines Consortium bivalirudin, 250mg powder for concentrate for solution for injection or infusion (Angiox ) No. (516/08) The Medicines Company UK Ltd 07 November 2008 The Scottish Medicines

More information

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Julinda Mehilli, MD Deutsches Herzzentrum Technische Universität Munich Germany ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Background Left main

More information

Clinical Lessons from BMC2-PCI

Clinical Lessons from BMC2-PCI Clinical Lessons from BMC2-PCI The Blue Cross Blue Shield of Michigan Cardiovascular Consortium Hitinder Gurm, M.D. University of Michigan Overview 32 papers since inception 10 papers published this year

More information

PROMUS Element Experience In AMC

PROMUS Element Experience In AMC Promus Element Luncheon Symposium: PROMUS Element Experience In AMC Jung-Min Ahn, MD. University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea PROMUS Element Clinical

More information

DECLARATION OF CONFLICT OF INTEREST

DECLARATION OF CONFLICT OF INTEREST DECLARATION OF CONFLICT OF INTEREST Multivessel disease and cardiogenic shock: CABG is the optimal revascularization therapy. Contra Prof. Christian JM Vrints Cardiogenic Shock Spiral Acute Myocardial

More information

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor 76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class

More information

Access Issues and Bleeding Complications

Access Issues and Bleeding Complications Cardiovascular Trends 2011: Nursing and Cath Lab Symposia ITS 2011 Access Issues and Bleeding Complications Mauricio G. Cohen, MD, FACC, FSCAI Director, Cardiac Catheterization Lab Associate Professor

More information

Access Closure: Manual vs. Device

Access Closure: Manual vs. Device Access Closure: Manual vs. Device Herbert D. Aronow, MD, MPH, FACC, FSCAI, FSVM Director, Interventional Cardiology, Cardiovascular Institute Director, Cardiac Cath Labs, Rhode Island &The Miriam Hospitals

More information

Journal of the American College of Cardiology Vol. 44, No. 9, by the American College of Cardiology Foundation ISSN /04/$30.

Journal of the American College of Cardiology Vol. 44, No. 9, by the American College of Cardiology Foundation ISSN /04/$30. Journal of the American College of Cardiology Vol. 44, No. 9, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.05.085

More information

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20. Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL

More information

STEMI update. Vijay Krishnamoorthy M.D. Interventional Cardiology

STEMI update. Vijay Krishnamoorthy M.D. Interventional Cardiology STEMI update Vijay Krishnamoorthy M.D. Interventional Cardiology OVERVIEW Current Standard of Care in Management of STEMI Update in management of STEMI Pre-Cath Lab In the ED/Office/EMS. Cath Lab Post

More information

UNIVERSITY OF OKLAHOMA INTERVENTIONAL CARDIOLOGY FELLOWSHIP CURRICULUM

UNIVERSITY OF OKLAHOMA INTERVENTIONAL CARDIOLOGY FELLOWSHIP CURRICULUM Curricular Components: UNIVERSITY OF OKLAHOMA INTERVENTIONAL CARDIOLOGY FELLOWSHIP The components of curriculum are: CURRICULUM 1. Cardiac Catheterization Laboratory: a. Competencies:,, Practice-Based

More information

Early Exercise After Coronary Stenting Is Safe

Early Exercise After Coronary Stenting Is Safe Journal of the American College of Cardiology Vol. 42, No. 9, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)01122-7

More information

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome Chris C. Cook, MD Associate Professor of Surgery Director, CT Residency Program, WVU ACOI 10/17/18 No Disclosures

More information

Clopidogrel Date: 15 July 2008

Clopidogrel Date: 15 July 2008 These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinicalTrials.gov

More information

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Clinical Seminar Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical

More information

PCI for Left Anterior Descending Artery Ostial Stenosis

PCI for Left Anterior Descending Artery Ostial Stenosis PCI for Left Anterior Descending Artery Ostial Stenosis Why do you hesitate PCI for LAD ostial stenosis? LAD Ostial Lesion Limitations of PCI High elastic recoil Involvement of the distal left main coronary

More information

bivalirudin 250mg powder for concentrate for solution for injection or infusion (Angiox) SMC No. (638/10) The Medicines Company

bivalirudin 250mg powder for concentrate for solution for injection or infusion (Angiox) SMC No. (638/10) The Medicines Company bivalirudin 250mg powder for concentrate for solution for injection or infusion (Angiox) SMC No. (638/10) The Medicines Company 06 August 2010 The Scottish Medicines Consortium (SMC) has completed its

More information

Journal of the American College of Cardiology Vol. 38, No. 3, by the American College of Cardiology ISSN /01/$20.

Journal of the American College of Cardiology Vol. 38, No. 3, by the American College of Cardiology ISSN /01/$20. Journal of the American College of Cardiology Vol. 38, No. 3, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01423-1 Effect

More information

Vascular Access: Management of Complications. Chris Burrell, South West Cardiothoracic Centre, Plymouth

Vascular Access: Management of Complications. Chris Burrell, South West Cardiothoracic Centre, Plymouth Vascular Access: Management of Complications Chris Burrell, South West Cardiothoracic Centre, Plymouth Alternative Vascular Access Sites Femoral Axillary Brachial Radial Ulnar Femoral v Radial Vascular

More information

Timing of Surgery After Percutaneous Coronary Intervention

Timing of Surgery After Percutaneous Coronary Intervention Timing of Surgery After Percutaneous Coronary Intervention Deepak Talreja, MD, FACC Bayview/EVMS/Sentara Outline/Highlights Timing of elective surgery What to do with medications Stopping anti-platelet

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Schulz Schüpke S, Helde S, Gewalt S; et al. Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical

More information

FFR vs. icecg in Coronary Bifurcations (FIESTA) - preliminary results. Dobrin Vassilev MD, PhD National Heart Hospital Sofia, Bulgaria

FFR vs. icecg in Coronary Bifurcations (FIESTA) - preliminary results. Dobrin Vassilev MD, PhD National Heart Hospital Sofia, Bulgaria FFR vs. icecg in Coronary Bifurcations (FIESTA) - preliminary results Dobrin Vassilev MD, PhD National Heart Hospital Sofia, Bulgaria I would like to express my personal gratitude to Dr. BK Koo for opening

More information

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines)

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines) Cardiovascular Health Nova Scotia Guideline Update Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines) Authors: Dr. M. Love, Dr. I. Bata, K. Harrigan

More information

Unprotected LM intervention

Unprotected LM intervention Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline

More information

Facilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction. Is it beneficial to patients?

Facilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction. Is it beneficial to patients? Facilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction Is it beneficial to patients? Seung-Jea Tahk, MD. PhD. Suwon, Korea Facilitated PCI.. background Degree of coronary flow at

More information

Management of Acute Myocardial Infarction

Management of Acute Myocardial Infarction Management of Acute Myocardial Infarction Prof. Hossam Kandil Professor of Cardiology Cairo University ST Elevation Acute Myocardial Infarction Aims Of Management Emergency care (Pre-hospital) Early care

More information

Gender-Based Outcomes in Percutaneous Coronary Intervention with Drug-Eluting Stents (from the National Heart, Lung, and Blood Institute Dynamic

Gender-Based Outcomes in Percutaneous Coronary Intervention with Drug-Eluting Stents (from the National Heart, Lung, and Blood Institute Dynamic Gender-Based Outcomes in Percutaneous Coronary Intervention with Drug-Eluting Stents (from the National Heart, Lung, and Blood Institute Dynamic Registry) J. D. Abbott, et al. Am J Cardiol (2007) 99;626-31

More information

ORIGINAL ARTICLE. Rescue PCI Versus a Conservative Approach for Failed Fibrinolysis in Patients with STEMI

ORIGINAL ARTICLE. Rescue PCI Versus a Conservative Approach for Failed Fibrinolysis in Patients with STEMI Heart Mirror Journal From Affiliated Egyptian Universities and Cardiology Centers Vol. 6, No. 3, 2012 ISSN 1687-6652 ORIGINAL ARTICLE for Failed Fibrinolysis in Patients with STEMI Mohamed Salem, MD, PhD;

More information

Cath Conference Kintur Sanghvi MD March 15, 2007

Cath Conference Kintur Sanghvi MD March 15, 2007 Cath Conference Kintur Sanghvi MD March 15, 2007 Case 1: 75 yr old female admitted with chest pain and abnormal stress test t Case 2: 70 yr F with typical exertional angina and HTN, dyslipidemia. Trans

More information

STEMI AND MULTIVESSEL CORONARY DISEASE

STEMI AND MULTIVESSEL CORONARY DISEASE STEMI AND MULTIVESSEL CORONARY DISEASE ΤΣΙΑΦΟΥΤΗΣ Ν. ΙΩΑΝΝΗΣ ΕΠΕΜΒΑΤΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ Α ΚΑΡΔΙΟΛΟΓΙΚΗ ΝΟΣ ΕΡΥΘΡΟΥ ΣΤΑΥΡΟΥ IRA 30-50% of STEMI patients have additional stenoses other than the infarct related

More information

MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION

MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION C. Graidis, D. Dimitriadis, A. Ntatsios, V. Karasavvides Euromedica Kyanous Stavros, Thessaloniki.

More information

Vascular Closure Device: A to Z. Owayed M Al Shammeri, MD, FSCAI Interventional Cardiologist AlRayyan Hospital, HMG Riyadh

Vascular Closure Device: A to Z. Owayed M Al Shammeri, MD, FSCAI Interventional Cardiologist AlRayyan Hospital, HMG Riyadh Vascular Closure Device: A to Z Owayed M Al Shammeri, MD, FSCAI Interventional Cardiologist AlRayyan Hospital, HMG Riyadh Femoral artery Anatomy Disparities still exist Vascular Closure Devices Suture

More information

Randomized Comparison of Prasugrel and Bivalirudin versus Clopidogrel and Heparin in Patients with ST-Segment Elevation Myocardial Infarction

Randomized Comparison of Prasugrel and Bivalirudin versus Clopidogrel and Heparin in Patients with ST-Segment Elevation Myocardial Infarction Randomized Comparison of Prasugrel and Bivalirudin versus Clopidogrel and Heparin in Patients with ST-Segment Elevation Myocardial Infarction The Bavarian Reperfusion Alternatives Evaluation (BRAVE) 4

More information

Guideline for STEMI. Reperfusion at a PCI-Capable Hospital

Guideline for STEMI. Reperfusion at a PCI-Capable Hospital MANSOURA. 2015 Guideline for STEMI Reperfusion at a PCI-Capable Hospital Mahmoud Yossof MANSOURA 2015 Reperfusion Therapy for Patients with STEMI *Patients with cardiogenic shock or severe heart failure

More information

1. Diabetes mellitus (DM) is associated with worse clinical and angiographic outcomes even in acute myocardial Infarction (AMI) patients.

1. Diabetes mellitus (DM) is associated with worse clinical and angiographic outcomes even in acute myocardial Infarction (AMI) patients. Midterm Clinical Outcomes of Insulin Requiring Diabetes Mellitus versus Non-insulin Dependent Diabetes Mellitus in Acute Myocardial Infarction Patients in Drug Eluting Stent Era : Insight from Korea Acute

More information

NCDR CathPCI Registry v4.4 Diagnostic Catheterization and Percutaneous Coronary Intervention Registry

NCDR CathPCI Registry v4.4 Diagnostic Catheterization and Percutaneous Coronary Intervention Registry A. DEMOGRAPHICS Last Name 2000 : First Name 2010 : Middle Name 2020 : SSN 2030 : - - - SSN N/A 2031 Patient ID 2040 : (auto) Other ID 2045 : Birth Date 2050 : *** @ Sex 2060 : *** @ O Male O Female Race:

More information

388-1 Poongnap-dong, Songpa-gu, Seoul, , Republic of Korea b Department of Medicine, Changi General Hospital, Singapore

388-1 Poongnap-dong, Songpa-gu, Seoul, , Republic of Korea b Department of Medicine, Changi General Hospital, Singapore International Journal of Cardiology 126 (2008) 224 228 www.elsevier.com/locate/ijcard Percutaneous coronary intervention with stenting of left main coronary artery with drug-eluting stent in the setting

More information

FFR in Multivessel Disease

FFR in Multivessel Disease FFR in Multivessel Disease April, 26 2013 Coronary Physiology in the Catheterization Laboratory Location: European Heart House, Nice, France Pim A.L. Tonino, MD, PhD Hartcentrum, Eindhoven, the Netherlands

More information

A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices

A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices Nipun Arora, MD, a Michael E. Matheny, MD, b,c Carrie Sepke,

More information

Mynx Vascular Closure Device Early Ambulation Study

Mynx Vascular Closure Device Early Ambulation Study Mynx Vascular Closure Device Early Ambulation Study The safety and benefits of 1-hour ambulation with the Mynx 5-F Vascular Closure Device. By Vikranth R. GongidI, DO; Ahsan Jafir, DO; and Vijay Verma,

More information

Predictors of restenosis and cardiovascular events in patients undergoing percutaneous angioplasty for subclavian/innominate artery stenosis

Predictors of restenosis and cardiovascular events in patients undergoing percutaneous angioplasty for subclavian/innominate artery stenosis Predictors of restenosis and cardiovascular events in patients undergoing percutaneous angioplasty for subclavian/innominate artery stenosis Tadeusz Przewlocki, Anna Kablak Ziembicka, Piotr Pieniazek,

More information

Premier Health Plan considers Intravascular Ultrasound (IVUS) for Coronary Vessels medically necessary for the following indications:

Premier Health Plan considers Intravascular Ultrasound (IVUS) for Coronary Vessels medically necessary for the following indications: Premier Health Plan POLICY AND PROCEDURE MANUAL MP.091.PH - Intravascular Ultrasound for Coronary Vessels This policy applies to the following lines of business: Premier Commercial Premier Employee Premier

More information

e Corrado Tamburino, MD, PhD

e Corrado Tamburino, MD, PhD Transcatheter Aortic Valve Implantation Stroke: etiology ogy and prevention e Corrado Tamburino, MD, PhD Full Professor of Cardiology, Director of Postgraduate School of Cardiology Chief Cardiovascular

More information

A Large Prospective Randomized Trial of DES vs BMS in Patients with STEMI

A Large Prospective Randomized Trial of DES vs BMS in Patients with STEMI HORIZONS-AMI: A Large Prospective Randomized Trial of DES vs BMS in Patients with STEMI Gregg W. Stone MD Columbia University Medical Center Cardiovascular Research Foundation Disclosures Gregg W. Stone

More information

Rationale for Percutaneous Revascularization ESC 2011

Rationale for Percutaneous Revascularization ESC 2011 Rationale for Percutaneous Revascularization Marie Claude Morice, Massy FR MD, FESC, FACC ESC 2011 Paris Villepinte - 27-31 August, 2011 Massy, France Potential conflicts of interest I have the following

More information

How to approach non-infarct related artery disease in patients with STEMI in a limited resource setting

How to approach non-infarct related artery disease in patients with STEMI in a limited resource setting How to approach non-infarct related artery disease in patients with STEMI in a limited resource setting Ahmed A A Suliman, MBBS, FACP, FESC Associate Professor, University of Khartoum Interventional Cardiologist,

More information

NCVD-PCI Registry. Percutaneous Coronary Intervention (PCI) Registry, MALAYSIA c/o National Heart Association of Malaysia

NCVD-PCI Registry. Percutaneous Coronary Intervention (PCI) Registry, MALAYSIA c/o National Heart Association of Malaysia NCVD-PCI Registry National Cardiovascular Disease Database (NCVD) National Cardiovascular Disease Database (NCVD) Percutaneous Coronary Intervention (PCI) Registry, MALAYSIA c/o National Heart Association

More information

Disclosures. Inpatient Management of Non-ST Elevation Acute Coronary Syndromes. Edward McNulty MD, FACC. None

Disclosures. Inpatient Management of Non-ST Elevation Acute Coronary Syndromes. Edward McNulty MD, FACC. None Inpatient Management of Non-ST Elevation Acute Coronary Syndromes Edward McNulty MD, FACC Assistant Clinical Professor UCSF Director, SF VAMC Cardiac Catheterization Laboratory Disclosures None New Guidelines

More information

Cardiovascular Health Nova Scotia Update to Antiplatelet Sections of the Nova Scotia Guidelines for Acute Coronary Syndromes, 2008.

Cardiovascular Health Nova Scotia Update to Antiplatelet Sections of the Nova Scotia Guidelines for Acute Coronary Syndromes, 2008. Cardiovascular Health Nova Scotia Update to Antiplatelet Sections of the Nova Scotia Guidelines for Acute Coronary Syndromes, 2008. ST Elevation Myocardial Infarction (STEMI)-Acute Coronary Syndrome Guidelines:

More information

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang

More information